MedPath

PAPAVERINE HYDROCHLORIDE INJECTION USP

PAPAVERINE HYDROCHLORIDE INJECTION USP

Approved
DIN Number

00009881

Drug Class

Human

Market Date

Dec 31, 1951

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00009881
AIG Number0107115001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
A03AD01 PAPAVERINE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous ,  Subcutaneous ,  Intramuscular
AHFS Classification24:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

PAPAVERINE HYDROCHLORIDEActive
Strength: 65 MG / 2 ML
Monograph: PAPAVERINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.